OAM
AVNR

Oxford Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Oxford Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-4,008,100
Closed -$67.7M – 855
2014
Q4 		$67.7M Buy
+4,008,100
New +$56.4M 1.49% 13

Oxford Asset Management's AVNR Position: Q1 2015 in Review

Oxford Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 4,008,100 shares — an estimated $67.7M sold.

Oxford Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $67.7M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Oxford Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Oxford Asset Management sold 4,008,100 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $67.7M.
  • Oxford Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
  • Oxford Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $67.7M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Oxford Asset Management's 13F filing for Q1 2015, filed 15 Apr 2015.